Cardiovascular failure and cardiogenic shock

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 5, 2011, Pages 598-606

  Patel, Ankitkumar K ^a   Hollenberg, Steven M ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Cardiogenic shock; echocardiography; inotropic therapy; intensive care; myocardial infarction; right heart catheterization; vasopressor therapy

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; DOPAMINE; HEART ENZYME; HEPARIN; LEVOSIMENDAN; MILRINONE; NORADRENALIN; VASOPRESSIN;

ACUTE HEART INFARCTION; ANGINA PECTORIS; AORTA VALVE REGURGITATION; ARTERIAL GAS; ARTIFICIAL VENTILATION; BLOOD CELL COUNT; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DIABETES CONTROL; DRUG HALF LIFE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART TAMPONADE; HUMAN; HYPERTENSION; HYPOTENSION; LEFT VENTRICULAR ASSIST DEVICE; LOADING DRUG DOSE; LUNG EMBOLISM; MITRAL VALVE REGURGITATION; MORTALITY; MYOCARDIAL HIBERNATION; OXYGEN THERAPY; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STUNNED HEART MUSCLE; TACHYCARDIA; TELEMETRY; THORAX RADIOGRAPHY; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE;

CARDIAC OUTPUT; CARDIOVASCULAR DISEASES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; SHOCK, CARDIOGENIC; TIME FACTORS;

EID: 80054060125     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1287869     Document Type: Review

References (58)

1. Sarswat N, Hollenberg S M. Cardiogenic shock. Hosp Pract (Minneap) 2010 38 1 74-83
2. Hochman J S., Boland J, Sleeper L A. et al, SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation 1995 91 3 873-881
3. Goldberg R J., Spencer F A., Gore J M., Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009 119 9 1211-1219
4. Hollenberg S M., Kavinsky C J., Parrillo J E. Cardiogenic shock. Ann Intern Med 1999 131 1 47-59 (Pubitemid 29310017)
5. Hollenberg S M. Recognition and treatment of cardiogenic shock. Semin Respir Crit Care Med 2004 25 6 661-671 (Pubitemid 40041586)
6. Hochman J S., Boland J, Sleeper L A. et al, SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. Circulation 1995 91 3 873-881
7. Holmes D R. Jr, Bates E R., Kleiman N S. et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995 26 3 668-674
8. Hollenberg S M., Kavinsky C J., Parrillo J E. Cardiogenic shock. Ann Intern Med 1999 131 1 47-59 (Pubitemid 29310017)
9. Hochman J S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003 107 24 2998-3002 (Pubitemid 36758968)
10. Picard M H., Davidoff R, Sleeper L A. et al, SHOCK Trial. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 2003 107 2 279-284 (Pubitemid 36135224)
11. Kohsaka S, Menon V, Lowe A M. et al, SHOCK Investigators. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 2005 165 14 1643-1650 (Pubitemid 41124160)
12. Jeger R V., Assmann S F., Yehudai L, Ramanathan K, Farkouh M E., Hochman J S. Causes of death and re-hospitalization in cardiogenic shock. Acute Card Care 2007 9 1 25-33 (Pubitemid 46622769)
13. Bolli R. Basic and clinical aspects of myocardial stunning. Prog Cardiovasc Dis 1998 40 6 477-516 (Pubitemid 28285175)
14. Gerber B L., Wijns W, Vanoverschelde J L. et al. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans. J Am Coll Cardiol 1999 34 7 1939-1946 (Pubitemid 30002648)
15. Wijns W, Vatner S F., Camici P G. Hibernating myocardium. N Engl J Med 1998 339 3 173-181
16. Kloner R A., Jennings R B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 2001 104 24 2981-2989 (Pubitemid 33139113)
17. Korewicki J. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure. Cardiol J 2009 16 6 493-499
18. Rose E A., Gelijns A C., Moskowitz A J. et al, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 345 20 1435-1443
19. Selman L, Harding R, Beynon T et al. Improving end-of-life care for patients with chronic heart failure: let's hope it'll get better, when I know in my heart of hearts it won't Heart 2007 93 8 963-967 (Pubitemid 47122049)
20. McCarthy R E. III, Boehmer J P., Hruban R H. et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000 342 10 690-695 (Pubitemid 30131421)
21. Gupta S, Markham D W., Drazner M H., Mammen P P. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med 2008 5 11 693-706
22. Klein R M., Vester E G., Brehm M U. et al. [Inflammation of the myocardium as an arrhythmia trigger]. Z Kardiol 2000 89 Suppl 3 24-35
23. Cooper L T. Jr. Myocarditis. N Engl J Med 2009 360 15 1526-1538
24. Wittstein I S., Thiemann D R., Lima J A. et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005 352 6 539-548 (Pubitemid 40204667)
25. Movahed M R. Important echocardiographic features of takotsubo or stress-induced cardiomyopathy that can aid early diagnosis. JACC Cardiovasc Imaging 2010 3 11 1200-1201 author reply 1201
26. Huffman C, Wagman G, Fudim M, Zolty R, Vittorio T. Reversible cardiomyopathiesa review. Transplant Proc 2010 42 9 3673-3678
27. Filsoufi F, Salzberg S P., Adams D H. Current management of ischemic mitral regurgitation. Mt Sinai J Med 2005 72 2 105-115 (Pubitemid 40458390)
28. Filsoufi F, Rahmanian P B., Anyanwu A, Adams D H. Physiologic basis for the surgical treatment of ischemic mitral regurgitation. Am Heart Hosp J 2006 4 4 261-268
29. Choudhry N K., Etchells E E. The rational clinical examination. Does this patient have aortic regurgitation? JAMA 1999 281 23 2231-2238 (Pubitemid 29275707)
30. Morganroth J, Perloff J K., Zeldis S M., Dunkman W B. Acute severe aortic regurgitation: pathophysiology, clinical recognition, and management. Ann Intern Med 1977 87 2 223-232 (Pubitemid 8165592)
31. Nohria A, Tsang S W., Fang J C. et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 2003 41 10 1797-1804 (Pubitemid 36584255)
32. de Denus S, Pharand C, Williamson D R. Brain natriuretic peptide in the management of heart failure: the versatile neurohormone. Chest 2004 125 2 652-668 (Pubitemid 38223648)
33. Maisel A S., Krishnaswamy P, Nowak R M. et al, Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 347 3 161-167 (Pubitemid 34764819)
34. Logeart D, Saudubray C, Beyne P et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002 40 10 1794-1800 (Pubitemid 35341958)
35. Antman E M., Hand M, Armstrong P W. et al, Canadian Cardiovascular Society American Academy of Family Physicians American College of Cardiology American Heart Association. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008 51 2 210-247
36. Hochman J S., Sleeper L A., Webb J G. et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999 341 9 625-634
37. Menon V, Slater J N., White H D., Sleeper L A., Cocke T, Hochman J S. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 2000 108 5 374-380 (Pubitemid 30162955)
38. Forrester J S., Diamond G, Chatterjee K, Swan H JC. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). N Engl J Med 1976 295 25 1404-1413 (Pubitemid 8004135)
39. De Backer D, Biston P, Devriendt J et al, SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010 362 9 779-789
40. Antman E M., Anbe D T., Armstrong P W. et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004 110 5 588-636 (Pubitemid 39036178)
41. Felker G M., Benza R L., Chandler A B. et al, OPTIME-CHF Investigators. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003 41 6 997-1003 (Pubitemid 36315544)
42. Elahi M M., Lam J, Asopa S, Matata B M. Levosimendan Versus an Intra-aortic Balloon Pump in Adult Cardiac Surgery Patients With Low Cardiac Output. J Cardiothorac Vasc Anesth 2011 Mar 2. [Epub ahead of print] No abstract available
43. Russ M A., Prondzinsky R, Christoph A et al. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 2007 35 12 2732-2739 (Pubitemid 350175769)
44. García-González M J., Domínguez-Rodríguez A, Ferrer-Hita J J., Abreu-González P, Muñoz M B. Cardiogenic shock after primary percutaneous coronary intervention: effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Fail 2006 8 7 723-728 (Pubitemid 44637270)
45. Mebazaa A, Nieminen M S., Packer M et al, SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007 297 17 1883-1891 (Pubitemid 46707842)
46. Bates E R., Stomel R J., Hochman J S., Ohman E M. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in cardiogenic shock. Int J Cardiol 1998 65 Suppl 1 S37-S42 (Pubitemid 28346555)
47. Barron H V., Every N R., Parsons L S. et al, Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001 141 6 933-939
48. Sanborn T A., Sleeper L A., Bates E R. et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 36 3, Suppl A 1123-1129
49. Thiele H, Sick P, Boudriot E et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005 26 13 1276-1283 (Pubitemid 41435457)
50. Burkhoff D, Cohen H, Brunckhorst C, O'Neill W W., TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006 152 3 469 e1-e8
51. Seyfarth M, Sibbing D, Bauer I et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008 52 19 1584-1588
52. Cheng J M., den Uil C A., Hoeks S E. et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009 30 17 2102-2108
53. Becker R C. Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock. Am Heart J 1993 125 3 919-929 (Pubitemid 23079875)
54. Hochman J S., Sleeper L A., White H D. et al, SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. One-year survival following early revascularization for cardiogenic shock. JAMA 2001 285 2 190-192 (Pubitemid 32048521)
55. Dzavik V, Sleeper L A., Picard M H. et al, SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK Investigators. Outcome of patients aged > or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J 2005 149 6 1128-1134 (Pubitemid 40848160)
56. White H D., Assmann S F., Sanborn T A. et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 2005 112 13 1992-2001 (Pubitemid 41377419)
57. Thompson C R., Buller C E., Sleeper L A. et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000 36 3, Suppl A 1104-1109
58. Antman E M., Anbe D T., Armstrong P W. et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004 110 5 588-636 (Pubitemid 39036178)